Bringing life-changing trials to every patient, everywhere.

Our mission is to

Create a world where all patients can access the right trials for them in their community, making medical research more accessible, inclusive, and efficient

Core issues where we make a difference

Access

Bring clinical trials to all patients, regardless of where they live

Diversity

Partner with sites to design inclusive trials and enroll representative patient populations

Speed

Accelerate trial timelines
to bring medical breakthroughs to patients, faster

Meet the people behind the vision

Kourosh Davarpanah

Co-founder & Chief Executive Officer

Liz Beatty

Co-founder & Chief Strategy Officer

Jean-David Zeitoun

Co-founder & Chief Medical Officer

Bastien Duret

Chief Technical Officer

Jennifer Koch

Vice President of Marketing

Carly Cooperstein

Vice President of Trial Delivery

Philippe Ravaud

Co-founder & Chief Scientific Officer

Remi Dupeuble

Vice President of Finance

Quentin Bodinier

Vice President of Product

Trusted by research leaders

Co-developing with pharma and site leaders for better, faster trials.

Our investors

Empowered by global investors committed to healthcare innovation

In the words of our founders

The AI drug discovery boom is coming. Whether you buy into the boldest projections or not, one thing is clear: clinical research is not ready.

Inato’s AI platform is built for this new era, connecting sponsors, sites, and patients to bring medical breakthroughs to more patients, faster.

Kourosh Davarpanah

Founder & CEO

For too long, clinical trials have been inaccessible, inefficient, and unrepresentative of the patients they aim to serve. We founded Inato to change this.

Our platform empowers sponsors to engage with sites at scale to design more inclusive trials, bring research into more communities globally, and ultimately reach more patients. Together, we’re reimagining how research happens.

Liz Beatty

Co-founder and Chief Strategy Officer

Our world-class team comes from